Literature DB >> 8485072

Calcium antagonists for congestive heart failure: is it really one bridge too far to cross?

L H Opie.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8485072     DOI: 10.1007/bf00878314

Source DB:  PubMed          Journal:  Cardiovasc Drugs Ther        ISSN: 0920-3206            Impact factor:   3.727


× No keyword cloud information.
  7 in total

1.  A comparison of enalapril with hydralazine-isosorbide dinitrate in the treatment of chronic congestive heart failure.

Authors:  J N Cohn; G Johnson; S Ziesche; F Cobb; G Francis; F Tristani; R Smith; W B Dunkman; H Loeb; M Wong
Journal:  N Engl J Med       Date:  1991-08-01       Impact factor: 91.245

2.  The effect of diltiazem on mortality and reinfarction after myocardial infarction.

Authors: 
Journal:  N Engl J Med       Date:  1988-08-18       Impact factor: 91.245

3.  Effect of verapamil on mortality and major events after acute myocardial infarction (the Danish Verapamil Infarction Trial II--DAVIT II)

Authors: 
Journal:  Am J Cardiol       Date:  1990-10-01       Impact factor: 2.778

4.  Atrial natriuretic peptide secretion: synergistic effect of phorbol ester and A23187.

Authors:  H Ruskoaho; M Toth; R E Lang
Journal:  Biochem Biophys Res Commun       Date:  1985-12-17       Impact factor: 3.575

5.  Calcium channel blockers in acute myocardial infarction and unstable angina: an overview.

Authors:  P H Held; S Yusuf; C D Furberg
Journal:  BMJ       Date:  1989-11-11

Review 6.  Calcium-channel blockade in the management of severe chronic congestive heart failure: a bridge too far.

Authors:  M Packer; P D Kessler; W H Lee
Journal:  Circulation       Date:  1987-06       Impact factor: 29.690

7.  Acute and chronic effects of the dihydropyridine calcium antagonist nisoldipine on the resting and exercise hemodynamics, neurohumoral parameters, and functional capacity of patients with chronic heart failure.

Authors:  L Dei Cas; M Metra; R Ferrari; O Visioli
Journal:  Cardiovasc Drugs Ther       Date:  1993-02       Impact factor: 3.727

  7 in total
  4 in total

Review 1.  Amlodipine. A reappraisal of its pharmacological properties and therapeutic use in cardiovascular disease.

Authors:  M Haria; A J Wagstaff
Journal:  Drugs       Date:  1995-09       Impact factor: 9.546

Review 2.  Cardioselectivity of calcium antagonists.

Authors:  T Godfraind
Journal:  Cardiovasc Drugs Ther       Date:  1994-05       Impact factor: 3.727

Review 3.  Vascular selective calcium entry blockers in the treatment of cardiovascular disorders: focus on felodipine.

Authors:  W C Little; C P Cheng; L Elvelin; M Nordlander
Journal:  Cardiovasc Drugs Ther       Date:  1995-10       Impact factor: 3.727

4.  Vasodilation-related adverse events in diltiazem and dihydropyridine calcium antagonists studied by prescription-event monitoring.

Authors:  K Kubota; G L Pearce; W H Inman
Journal:  Eur J Clin Pharmacol       Date:  1995       Impact factor: 2.953

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.